Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Astellas Pharma Global Development, Inc.

Clinical trials sponsored by Astellas Pharma Global Development, Inc., explained in plain language.

Trials to join now! 20 Not yet recruiting 1 Not yet finished but already full! 12 Completed 12 Terminated 7

New hope for Hard-to-Treat lung cancer: targeted drug setidegrasib takes on KRAS G12D mutation

Disease control Not yet recruiting

This study tests a new drug, setidegrasib, against a standard chemotherapy (docetaxel) in people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12D. Participants must have already tried platinum-based chemo and immunotherapy. The goal is …

Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control

Last updated May 22, 2026 14:03 UTC